Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NHS Awards Cytogenetics Tender to OGT

Published: Tuesday, February 04, 2014
Last Updated: Tuesday, February 04, 2014
Bookmark and Share
OGT has been awarded a significant tender by the UK National Health Service for the supply of oligo-based arrays for cytogenetics.

Involving the cooperation of a number of health authorities, the tender’s comprehensive validation process sets an excellent example for future procurement procedures. The resulting two-year agreement covers a consortium of four UK NHS Genetics Labs (Bristol, Manchester, Salisbury and Sheffield), with an additional eight labs (Birmingham, Cambridge, Cardiff, Great Ormond Street, Leeds, Leicester, Nottingham and Oxford) able to take advantage of the agreed supply framework. 

In order to assess the quality of the products, each Trust laboratory submitted a variety of samples for processing. OGT was successful against a number of alternative array providers with its CytoSure ISCA 8x60k platform, designed in collaboration with the International Collaboration for Clinical Genomics (ICCG)*, to deliver standardised, evidence-based designs to the cytogenetic research community. OGT was the only supplier whose product correctly identified all the genetic abnormalities tested. The success was attributed to a combination of the array and associated CytoSure Interpret Software performance, which delivers reliable and user-friendly data analysis, providing rapid access to meaningful results. This software is provided by OGT with all CytoSure arrays.

Leading the tender process was Mr Chris Wragg, BSc., FCRPath, Head of Molecular Cytogenetics at the Bristol Genetics Laboratory. He commented: “An exhaustive procurement and evaluation process was employed as, while we want to identify the most financially viable option, we can’t afford to compromise on quality. OGT was the only company able to deliver on quality, providing the best proposal, product and customer service. What we have achieved here is an excellent model for future procurements - it has delivered savings without compromising on quality.”

Dr Mike Evans, CEO of OGT said: “We are delighted with the result of this exceptionally well-run tender. It is a testament to our strong emphasis on not only the highest quality products and services but also customer support. We are pleased to continue our relationships with Bristol, Manchester, and Salisbury and are looking forward to welcoming Sheffield and the other Trusts to our group.”

*Formerly known as the International Standards for Cytogenomic Arrays (ISCA) Consortium.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Genetic Markers Influence Addiction
Differences in vulnerability to cocaine addiction and relapse linked to both inherited traits and epigenetics, U-M researchers find.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Fructose Alters Hundreds of Brain Genes
UCLA scientists report that diet rich in omega-3 fatty acids can reverse the damage.
DNA Barcodes Gone Wild
A team of researchers at University of Toronto’s Donnelly Centre and Sinai Health System’s Lunenfeld-Tanenbaum Research Institute (LTRI) has developed a new technology that can stitch together DNA barcodes inside a cell to simultaneously search amongst millions of protein pairs for protein interactions.
New Genetic Risk Factors for Myopia Discovered
Genes and environment determine short-sightedness.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!